ANIP

ANI Pharmaceuticals Inc

ANIP, USA

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

https://www.anipharmaceuticals.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
ANIP
stock
ANIP

Understanding Momentum Shifts in (ANIP) Stock Traders Daily

Read more →
ANIP
stock
ANIP

3 Value Stocks with Questionable Fundamentals Finviz

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$110.375

Analyst Picks

Strong Buy

3

Buy

2

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

53.02

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

3.54

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

4.77 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.71 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

16.63 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.78

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 82.83% of the total shares of ANI Pharmaceuticals Inc

1.

BlackRock Inc

(11.898%)

since

2025/06/30

2.

Vanguard Group Inc

(5.8895%)

since

2025/06/30

3.

iShares Core S&P Small-Cap ETF

(4.6655%)

since

2025/08/31

4.

Millennium Management LLC

(4.6286%)

since

2025/06/30

5.

Global Alpha Capital Management Ltd.

(3.9748%)

since

2025/06/30

6.

State Street Corp

(3.3018%)

since

2025/06/30

7.

Deep Track Capital, LP

(3.2275%)

since

2025/06/30

8.

Vanguard Total Stock Mkt Idx Inv

(2.7066%)

since

2025/07/31

9.

Citadel Advisors Llc

(2.6264%)

since

2025/06/30

10.

Dimensional Fund Advisors, Inc.

(2.5538%)

since

2025/06/30

11.

Ranger Investment Management LP

(2.4632%)

since

2025/06/30

12.

William Blair Investment Management, LLC

(2.2617%)

since

2025/06/30

13.

iShares Russell 2000 ETF

(2.0271%)

since

2025/08/31

14.

Geode Capital Management, LLC

(1.9713%)

since

2025/06/30

15.

Macquarie Group Ltd

(1.9536%)

since

2025/06/30

16.

UBS Group AG

(1.866%)

since

2025/06/30

17.

Ameriprise Financial Inc

(1.764%)

since

2025/06/30

18.

CC&L Global Alpha - Series A

(1.7295%)

since

2025/07/31

19.

Nuveen, LLC

(1.7105%)

since

2025/06/30

20.

Aberdeen Group PLC

(1.6872%)

since

2025/06/30

21.

Ranger Small Cap

(1.6561%)

since

2025/06/30

22.

TANG CAPITAL MANAGEMENT LLC

(1.4639%)

since

2025/06/30

23.

Kennedy Capital Management Inc

(1.2312%)

since

2025/06/30

24.

Macquarie Small Cap Growth C

(1.2211%)

since

2025/07/31

25.

JPMorgan Chase & Co

(1.2123%)

since

2025/06/30

26.

Rubric Capital Management LP

(1.188%)

since

2025/06/30

27.

CREF Stock R3

(0.9737%)

since

2025/07/31

28.

Vanguard Institutional Extnd Mkt Idx Tr

(0.8435%)

since

2025/07/31

29.

Fidelity Small Cap Index

(0.8408%)

since

2025/06/30

30.

William Blair Small Cap Value I

(0.8187%)

since

2025/07/31

31.

iShares Russell 2000 Growth ETF

(0.7276%)

since

2025/08/31

33.

iShares S&P Small-Cap 600 Growth ETF

(0.6735%)

since

2025/08/31

34.

Columbia Small Cap Value Discv A

(0.6433%)

since

2025/07/31

35.

Oberweis Micro-Cap

(0.6404%)

since

2025/06/30

36.

Oberweis Micro-Cap Growth

(0.6404%)

since

2025/06/30

37.

Kennedy Small Cap Value

(0.6301%)

since

2025/06/30

38.

Columbia Small Cap Value Discovery Fund

(0.6258%)

since

2025/06/30

39.

abrdn US Equity Small Cap

(0.6005%)

since

2025/06/30

40.

abrdn US Small Cap Equity Inst Svc

(0.5944%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

2.04

Latest Release

Date

2025-09-30

EPS Actual

2.04

EPS Estimate

1.76

EPS Difference

0.28

Surprise Percent

15.9091%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Moderately Defensive(5.5)
Dividend
Decent Dividend Payer(3.5)
Economic Moat
Wide Moat Company(6.3)
GARP
Fair GARP(6)
Growth
Moderate Growth(5.5)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(6)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.